News - Mergers & Acquisitions, Vectura


Popular Filters

Vectura sets up JV, Kinnovata, for new respiratory business in China


UK-based developer of inhaled therapies Vectura (LSE: VEC) saw its shares rise 4.8% to 96.93 pence in…

Asia-PacificMergers & AcquisitionsPharmaceuticalProductionRespiratory and PulmonaryTianjin KingYorkTianjin Kinnovata PharmaVecturaZendex Bio Strategy

US deal for Vectura; takeover bid for AMAG


There was good news this morning from Vectura Group (LSE: VEC), a UK-based inhalation product development…

Allos TherapeuticsAMAG PharmaceuticalsLicensingMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top